Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Por Criscitiello, Carmen, Fumagalli, Debora, Saini, Kamal S, Loi, Sherene
Publicado em 2010

No significant viral transcription detected in whole breast cancer transcriptomes

Por Fimereli, Danai, Gacquer, David, Fumagalli, Debora, Salgado, Roberto, Rothé, Françoise, Larsimont, Denis, Sotiriou, Christos, Detours, Vincent
Publicado no BMC Cancer (2015)

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

Por Paik Soonmyung, Choi Hyun-Joo, Kim Seung-Il, Taniyama Yusuke, Gavin Patrick G, Fumagalli Debora, Pogue-Geile Katherine L
Publicado em 2010-03-01

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

Por Fumagalli, Debora, Gavin, Patrick G, Taniyama, Yusuke, Kim, Seung-Il, Choi, Hyun-Joo, Paik, Soonmyung, Pogue-Geile, Katherine L
Publicado em 2010

Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis

Por Azim, Hatem A., Singhal, Sandeep, Ignatiadis, Michail, Desmedt, Christine, Fumagalli, Debora, Veys, Isabelle, Larsimont, Denis, Piccart, Martine, Michiels, Stefan, Sotiriou, Christos
Publicado em 2013

Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis

Por Azim, Hatem A., Singhal, Sandeep, Ignatiadis, Michail, Desmedt, Christine, Fumagalli, Debora, Veys, Isabelle, Larsimont, Denis, Piccart, Martine, Michiels, Stefan, Sotiriou, Christos
Publicado em 2013

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer

Por Loi, Sherene, Michiels, Stefan, Lambrechts, Diether, Fumagalli, Debora, Claes, Bart, Kellokumpu-Lehtinen, Pirkko-Liisa, Bono, Petri, Kataja, Vesa, Piccart, Martine J., Joensuu, Heikki, Sotiriou, Christos
Publicado em 2013

The footprint of the ageing stroma in older patients with breast cancer

Por Brouwers, Barbara, Fumagalli, Debora, Brohee, Sylvain, Hatse, Sigrid, Govaere, Olivier, Floris, Giuseppe, Van den Eynde, Kathleen, Bareche, Yacine, Schöffski, Patrick, Smeets, Ann, Neven, Patrick, Lambrechts, Diether, Sotiriou, Christos, Wildiers, Hans
Publicado no Breast Cancer Res (2017)

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial

Por Sonnenblick, Amir, Brohée, Sylvain, Fumagalli, Debora, Rothé, Françoise, Vincent, Delphine, Ignatiadis, Michael, Desmedt, Christine, Salgado, Roberto, Sirtaine, Nicolas, Loi, Sherene, Neven, Patrick, Loibl, Sibylle, Denkert, Carsten, Joensuu, Heikki, Piccart, Martine, Sotiriou, Christos
Publicado no Oncotarget (2015)

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology

Por Fumagalli, Debora, Blanchet-Cohen, Alexis, Brown, David, Desmedt, Christine, Gacquer, David, Michiels, Stefan, Rothé, Françoise, Majjaj, Samira, Salgado, Roberto, Larsimont, Denis, Ignatiadis, Michail, Maetens, Marion, Piccart, Martine, Detours, Vincent, Sotiriou, Christos, Haibe-Kains, Benjamin
Publicado no BMC Genomics (2014)

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data

Por Lönnstedt, Ingrid M, Caramia, Franco, Li, Jason, Fumagalli, Debora, Salgado, Roberto, Rowan, Andrew, Salm, Max, Kanu, Nnennaya, Savas, Peter, Horswell, Stuart, Gade, Stephan, Loibl, Sibylle, Neven, Patrick, Sotiriou, Christos, Swanton, Charles, Loi, Sherene, Speed, Terence P
Publicado no Genome Biol (2014)

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome

Por Fumagalli, Debora, Gacquer, David, Rothé, Françoise, Lefort, Anne, Libert, Frederick, Brown, David, Kheddoumi, Naima, Shlien, Adam, Konopka, Tomasz, Salgado, Roberto, Larsimont, Denis, Polyak, Kornelia, Willard-Gallo, Karen, Desmedt, Christine, Piccart, Martine, Abramowicz, Marc, Campbell, Peter J., Sotiriou, Christos, Detours, Vincent
Publicado no Cell Rep (2015)

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer

Por Sonnenblick, Amir, Brohée, Sylvain, Fumagalli, Debora, Vincent, Delphine, Venet, David, Ignatiadis, Michail, Salgado, Roberto, Van den Eynden, Gert, Rothé, Françoise, Desmedt, Christine, Neven, Patrick, Loibl, Sibylle, Denkert, Carsten, Joensuu, Heikki, Loi, Sherene, Sirtaine, Nicolas, Kellokumpu-Lehtinen, Pirkko-Liisa, Piccart, Martine, Sotiriou, Christos
Publicado no BMC Med (2015)

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Por Gavin, Patrick G., Colangelo, Linda H., Fumagalli, Debora, Tanaka, Noriko, Remillard, Matthew Y., Yothers, Greg, Kim, Chungyeul, Taniyama, Yusuke, Kim, Seung Il, Choi, Hyun Joo, Blackmon, Nicole L., Lipchik, Corey, Petrelli, Nicholas J., O'Connell, Michael J., Wolmark, Norman, Paik, Soonmyung, Pogue-Geile, Kay L.
Publicado no Clin Cancer Res (2012)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group

Por Maetens, Marion, Brown, David, Irrthum, Alexandre, Aftimos, Philippe, Viale, Giuseppe, Loibl, Sibylle, Laes, Jean-François, Campbell, Peter J., Thompson, Alastair, Cortes, Javier, Seiler, Sabine, Vinnicombe, Sara, Oliveira, Mafalda, Rothé, Françoise, Bareche, Yacine, Fumagalli, Debora, Zardavas, Dimitrios, Desmedt, Christine, Piccart, Martine, Loi, Sherene, Sotiriou, Christos
Publicado no NPJ Breast Cancer (2017)

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phas...

Por Sonnenblick, Amir, Agbor-Tarh, Dominique, Bradbury, Ian, Di Cosimo, Serena, Azim, Hatem A., Fumagalli, Debora, Sarp, Severine, Wolff, Antonio C., Andersson, Michael, Kroep, Judith, Cufer, Tanja, Simon, Sergio D., Salman, Pamela, Toi, Masakazu, Harris, Lyndsay, Gralow, Julie, Keane, Maccon, Moreno-Aspitia, Alvaro, Piccart-Gebhart, Martine, de Azambuja, Evandro
Publicado no J Clin Oncol (2017)

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

Por Majewski, Ian J., Nuciforo, Paolo, Mittempergher, Lorenza, Bosma, Astrid J., Eidtmann, Holger, Holmes, Eileen, Sotiriou, Christos, Fumagalli, Debora, Jimenez, Jose, Aura, Claudia, Prudkin, Ludmila, Díaz-Delgado, Maria Carmen, de la Peña, Lorena, Loi, Sherene, Ellis, Catherine, Schultz, Nikolaus, de Azambuja, Evandro, Harbeck, Nadia, Piccart-Gebhart, Martine, Bernards, René, Baselga, José
Publicado no J Clin Oncol (2015)

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

Por Kim, Chungyeul, Tang, Gong, Pogue-Geile, Katherine L., Costantino, Joseph P., Baehner, Frederick L., Baker, Joffre, Cronin, Maureen T., Watson, Drew, Shak, Steven, Bohn, Olga L., Fumagalli, Debora, Taniyama, Yusuke, Lee, Ahwon, Reilly, Megan L., Vogel, Victor G., McCaskill-Stevens, Worta, Ford, Leslie G., Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman, Paik, Soonmyung
Publicado em 2011

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial

Por Fumagalli, Debora, Venet, David, Ignatiadis, Michail, Azim, Hatem A., Maetens, Marion, Rothé, Françoise, Salgado, Roberto, Bradbury, Ian, Pusztai, Lajos, Harbeck, Nadia, Gomez, Henry, Chang, Tsai-Wang, Coccia-Portugal, Maria Antonia, Di Cosimo, Serena, de Azambuja, Evandro, de la Peña, Lorena, Nuciforo, Paolo, Brase, Jan C., Huober, Jens, Baselga, José, Piccart, Martine, Loi, Sherene, Sotiriou, Christos
Publicado no JAMA Oncol (2017)

Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO su...

Por Ponde, Noam, Bradbury, Ian, Lambertini, Matteo, Ewer, Michael, Campbell, Christine, Ameels, Helene, Zardavas, Dimitrios, Di Cosimo, Serena, Baselga, José, Huober, Jens, Izquierdo, Miguel, Fumagalli, Debora, Bozovic-Spasojevic, Ivana, Maetens, Marion, Harbeck, Nadia, Pusztai, Lajos, Berghorn, Michael, Im, Young-Hyuck, Borrego, Manuel Ruiz, Chen, Dar-Ren, Rodeheffer, Richard, Piccart, Martine, Suter, Thomas, de Azambuja, Evandro
Publicado no Breast Cancer Res Treat (2017)